ID   NIT2_HUMAN              Reviewed;         276 AA.
AC   Q9NQR4; B2R9A3; D3DN47; Q8WUF0;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   15-MAR-2017, entry version 125.
DE   RecName: Full=Omega-amidase NIT2;
DE            EC=3.5.1.3;
DE   AltName: Full=Nitrilase homolog 2;
GN   Name=NIT2; ORFNames=CUA002;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10959838; DOI=10.1016/S0960-9822(00)00621-7;
RA   Pace H.C., Hodawadekar S.C., Draganescu A., Huang J., Bieganowski P.,
RA   Pekarsky Y., Croce C.M., Brenner C.;
RT   "Crystal structure of the worm NitFhit Rosetta stone protein reveals a
RT   Nit tetramer binding two Fhit dimers.";
RL   Curr. Biol. 10:907-917(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Adrenal tumor;
RA   Xu X., Yang Y., Gao G., Xiao H., Chen Z., Han Z.;
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-231.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=14528910;
RA   Myung J.K., Gulesserian T., Fountoulakis M., Lubec G.;
RT   "Deranged hypothetical proteins Rik protein, Nit protein 2 and
RT   mitochondrial inner membrane protein, Mitofilin, in fetal Down
RT   syndrome brain.";
RL   Cell. Mol. Biol. 49:739-746(2003).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [8]
RP   TISSUE SPECIFICITY, FUNCTION, SUBCELLULAR LOCATION, AND MASS
RP   SPECTROMETRY.
RX   PubMed=17488281; DOI=10.1111/j.1742-4658.2007.05828.x;
RA   Lin C.-H., Chung M.-Y., Chen W.-B., Chien C.-H.;
RT   "Growth inhibitory effect of the human NIT2 gene and its allelic
RT   imbalance in cancers.";
RL   FEBS J. 274:2946-2956(2007).
RN   [9]
RP   FUNCTION, SUBUNIT, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=19595734; DOI=10.1016/j.biochi.2009.07.003;
RA   Krasnikov B.F., Chien C.-H., Nostramo R., Pinto J.T., Nieves E.,
RA   Callaway M., Sun J., Huebner K., Cooper A.J.L.;
RT   "Identification of the putative tumor suppressor Nit2 as omega-
RT   amidase, an enzyme metabolically linked to glutamine and asparagine
RT   transamination.";
RL   Biochimie 91:1072-1080(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Has a omega-amidase activity. The role of omega-amidase
CC       is to remove potentially toxic intermediates by converting alpha-
CC       ketoglutaramate and alpha-ketosuccinamate to biologically useful
CC       alpha-ketoglutarate and oxaloacetate, respectively. Overexpression
CC       decreases the colony-forming capacity of cultured cells by
CC       arresting cells in the G2 phase of the cell cycle.
CC       {ECO:0000269|PubMed:17488281, ECO:0000269|PubMed:19595734}.
CC   -!- CATALYTIC ACTIVITY: A monoamide of a dicarboxylate + H(2)O = a
CC       dicarboxylate + NH(3).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.009 mM for alpha-ketoglutaramate (open-chain form)
CC         {ECO:0000269|PubMed:19595734};
CC         Vmax=5.9 umol/min/mg enzyme with alpha-ketoglutaramate as
CC         substrate {ECO:0000269|PubMed:19595734};
CC         Note=In solution, alpha-ketoglutaramate is in equilibrium with a
CC         cyclic form (2-hydroxy-5-oxoproline), and at pH 8.0 or above,
CC         the rate of ring opening is no longer limiting for the omega-
CC         amidase reaction.;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:19595734}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17488281}.
CC   -!- TISSUE SPECIFICITY: Detected in fetal brain (at protein level).
CC       Ubiquitous. Detected in heart, brain, placenta, lung, liver,
CC       skeletal muscle, kidney, pancreas, prostate, spleen, thymus,
CC       prostate, testis, ovary, small intestine and colon.
CC       {ECO:0000269|PubMed:14528910, ECO:0000269|PubMed:17488281}.
CC   -!- MASS SPECTROMETRY: Mass=30585; Method=MALDI; Range=1-276;
CC       Evidence={ECO:0000269|PubMed:17488281};
CC   -!- SIMILARITY: Belongs to the carbon-nitrogen hydrolase superfamily.
CC       NIT1/NIT2 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF284574; AAF87103.1; -; mRNA.
DR   EMBL; AF260334; AAG44665.1; -; mRNA.
DR   EMBL; AK313704; BAG36450.1; -; mRNA.
DR   EMBL; CH471052; EAW79824.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79825.1; -; Genomic_DNA.
DR   EMBL; BC020620; AAH20620.1; -; mRNA.
DR   EMBL; BC107890; AAI07891.1; -; mRNA.
DR   CCDS; CCDS33806.1; -.
DR   RefSeq; NP_064587.1; NM_020202.4.
DR   UniGene; Hs.439152; -.
DR   ProteinModelPortal; Q9NQR4; -.
DR   SMR; Q9NQR4; -.
DR   BioGrid; 121278; 25.
DR   IntAct; Q9NQR4; 2.
DR   STRING; 9606.ENSP00000377696; -.
DR   iPTMnet; Q9NQR4; -.
DR   PhosphoSitePlus; Q9NQR4; -.
DR   BioMuta; NIT2; -.
DR   DMDM; 74725271; -.
DR   REPRODUCTION-2DPAGE; IPI00549467; -.
DR   UCD-2DPAGE; Q9NQR4; -.
DR   EPD; Q9NQR4; -.
DR   PaxDb; Q9NQR4; -.
DR   PeptideAtlas; Q9NQR4; -.
DR   PRIDE; Q9NQR4; -.
DR   DNASU; 56954; -.
DR   Ensembl; ENST00000394140; ENSP00000377696; ENSG00000114021.
DR   GeneID; 56954; -.
DR   KEGG; hsa:56954; -.
DR   CTD; 56954; -.
DR   DisGeNET; 56954; -.
DR   GeneCards; NIT2; -.
DR   HGNC; HGNC:29878; NIT2.
DR   HPA; HPA036999; -.
DR   neXtProt; NX_Q9NQR4; -.
DR   OpenTargets; ENSG00000114021; -.
DR   PharmGKB; PA134882857; -.
DR   eggNOG; KOG0806; Eukaryota.
DR   eggNOG; COG0388; LUCA.
DR   GeneTree; ENSGT00550000074838; -.
DR   HOGENOM; HOG000222700; -.
DR   HOVERGEN; HBG105126; -.
DR   InParanoid; Q9NQR4; -.
DR   KO; K13566; -.
DR   OMA; NPWGEVI; -.
DR   OrthoDB; EOG091G0IKZ; -.
DR   PhylomeDB; Q9NQR4; -.
DR   TreeFam; TF300747; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   GenomeRNAi; 56954; -.
DR   PRO; PR:Q9NQR4; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114021; -.
DR   CleanEx; HS_NIT2; -.
DR   ExpressionAtlas; Q9NQR4; baseline and differential.
DR   Genevisible; Q9NQR4; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0050152; F:omega-amidase activity; IDA:BHF-UCL.
DR   GO; GO:0006528; P:asparagine metabolic process; IDA:BHF-UCL.
DR   GO; GO:0006541; P:glutamine metabolic process; IDA:BHF-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006107; P:oxaloacetate metabolic process; IDA:BHF-UCL.
DR   Gene3D; 3.60.110.10; -; 1.
DR   InterPro; IPR003010; C-N_Hydrolase.
DR   Pfam; PF00795; CN_hydrolase; 1.
DR   SUPFAM; SSF56317; SSF56317; 1.
DR   PROSITE; PS50263; CN_HYDROLASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Cytoplasm; Hydrolase; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    276       Omega-amidase NIT2.
FT                                /FTId=PRO_0000320252.
FT   DOMAIN        4    270       CN hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   ACT_SITE     43     43       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   ACT_SITE    112    112       Proton donor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   ACT_SITE    153    153       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   MOD_RES      26     26       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      68     68       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JHW2}.
FT   MOD_RES      68     68       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JHW2}.
FT   MOD_RES     123    123       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9JHW2}.
FT   MOD_RES     130    130       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9JHW2}.
FT   VARIANT     231    231       V -> A (in dbSNP:rs17851799).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_039180.
SQ   SEQUENCE   276 AA;  30608 MW;  32FA797601A419C6 CRC64;
     MTSFRLALIQ LQISSIKSDN VTRACSFIRE AATQGAKIVS LPECFNSPYG AKYFPEYAEK
     IPGESTQKLS EVAKECSIYL IGGSIPEEDA GKLYNTCAVF GPDGTLLAKY RKIHLFDIDV
     PGKITFQESK TLSPGDSFST FDTPYCRVGL GICYDMRFAE LAQIYAQRGC QLLVYPGAFN
     LTTGPAHWEL LQRSRAVDNQ VYVATASPAR DDKASYVAWG HSTVVNPWGE VLAKAGTEEA
     IVYSDIDLKK LAEIRQQIPV FRQKRSDLYA VEMKKP
//
